Endocrine Flashcards
hormones produced by basophils of anterior pituitary
FSH, LH, ACTH, TSH
“B-FLAT”
hormones produced by acidophils of anterior pituitary
GH, PRL
GLUT 1 found in
RBCs, brain, cornea, placenta
GLUT 2 found in
islet cells, liver, kidney, small intestine. it’s bidirectional
GLUT 3 found in
brain, placenta
GLUT 4 found in
adipose tissue, striated muscle. This is the only one that is insulin dependent
GLUT 5 found in
spermatocytes, GI tract. used for fructose
insulin receptors are of which class
tyrosine kinase
effect of insulin on Na+
increases retention in kidneys
effect of TRH
increases TSH and prolactin
effect of somatostatin on pituitary
decreases GH and TSH
effect of dopamine on pituitary
decreases prolactin and TSH
effect of PRL on hormone release
decreases GnRH
ADH acts on vessels via which receptor
V1
ADH acts on kidneys via which receptor
V2
17-hydroxylase def: effects on BP, cortisol, and sex hormones
increased BP
decreased sex hormones and cortisol
21-hydroxylase def: effects on BP, cortisol, and sex hormones
increased sex hormones
decreased BP and cortisol
11-hydroxylase def: effects on BP, cortisol, and sex hormones
increased sex hormones and BP
decreased cortisol
labs 17-hydroxylase deficiency
decreased androstenedione
labs 21-hydroxylase deficiency
increased renin, increased 17-hydroxyprogresterone
labs 11-hydroxylase deficiency
decreased renin
ACTH activates
cholesterol desmolase to form pregnenolone
physiologic effects of vitamin D
increases gut absorption of Ca and phosphate
which cells produce PTH
chief cells of parathyroid
effect of moderately low Mg2+ on PTH release
increases
effect of extremely low Mg2+ on PTH release
decreases
which cells produce calcitonin
parafollicular (C cells) of thyroid
physiologic effects of calcitonin
mainly/only decreases bone resorption
BNP, ANP, EDRF (for NO) use this signaling pathway
cGMP
FSH, LH, TSH, hCG, CRH, ADH (V2), MSH, PTH use this signaling pathway
cAMP
calcitonin, GHRH, glucagon use this signaling pathway
cAMP
GnRH, oxytocin, ADH (V1), TRH, H1, AT II, gastrin use this pathway
IP3
insulin, IGF-1, FGF, PDGF, EGF use this signaling pathway
receptor tyrosine kinase (MAP kinase)
prolactin, immunomodulators, GH, G-CSF, EPO, and TPO use this signaling pathway
non-receptor tyrosine kinase (JAK/STAT)
histology of neuroblastoma (adrenal)
Homer-Wright rosettes
germline cases of pheochromocytoma are associated with which mutations
NF1, VHL RET (MEN 2a, 2b)
cholesterol level in hypothyroidism
hypercholesterolemia (decreased LDL receptor)
cholesterol level in hyperthyroidism
hypocholesterolemia (increased LDL receptor)
HLA association Hashimoto
DR5
which non-neoplastic thyroid disease has Hurthle cells
Hashimoto
Wolf-Chaikoff effect
thyroid gland downregulates due to increased iodide
Jod-Basedown phenomenon
thyrotoxicosis if you repleat an iodine-deficient person who has autonomous thyroid tissue
which cancer has orphan annie eyes
papillary thyroid cancer
which thyroid cancer is associated with psammoma bodies
papillary thyroid cancer
which is a cancer of thyroid c cells
medullary carcinoma
which thyroid cancer is associated with hematogenous spread
follicular carcinoma
which thyroid cancer is associated with childhood irradiation
papillary carcinoma
what is Nelson syndrome
enlargment of ACTH-secreting pituitary adenoma after removing both adrenals
GH receptor antagonist used for acromegaly
pegvisomant
what is Laron syndrome
dwarfism due to defective GH receptors
T1DM HLA associations
DR3, DR4
presentation of glucagonoma
dermatitis (necrolytic migratory erythemia) diabetes, DVT, declining weight, depression
test to suppress gastrin levels/dx ZE
secretin administration
MEN 1
pituitary tumor, pancreatic tumor, parathyroid adenoma
MEN 2a
pheochromocytoma, medullary carcinoma of the thyroid, parathyroid hyperplasia
MEN 2b
pheochromocytoma, medullary carcinoma of the thyroid, and mucosal neuromas. Also associated with marfanoid habitus
RET is on chromosome…
10
MEN1 gene is on chromosome…
11
MOA metformin
decreases gluconeogensis, increase glycolysis and peripheral glucose utilization
MOA sulfonylureas
close K+ channel to increase insulin release
class of drugs: chlorpropamide, tolbutamide
first generation sulfonylureas
class of drugs: glimepiride, glipizide, glyburide
second generation sulfonylureas
MOA glitazones/thiazolidinediones
increase insulin sensitivity, bind PPAR-gamma
MOA meglitinides
bind K+ channel (different site than sulfonylureas)
class of drugs: exenatide, liralutide
GLP-1 analogs
class of drugs: linagliptin, saxagliptin, sitagliptin
DDP4 inhibitors
class of drugs pramlintide
amylin analog
MOA amylin
decrease gastric emptying and glucagon
oral hypoglycemic drugs that do not require islet function
metformin, amylin, SGLT-2 inhibitors (but these aren’t used in type 1)
class of drugs: acarbose, miglitol
alpha-glucosidase inhibitors
class of drugs conivaptan, tolvaptan
ADH receptor antagonists
MOA fludrocortisone
aldosterone analog with little glucocorticoid effects
cinacalcet MOA
sensitizes CaSR to decrease PTH release